| Compliance Training Webinar |
|
|
|
|
|
|
|
Understanding the Current FDA Requirements for Raw Materials and Components
|
|
|
This webinar covers the current FDA requirement that all raw materials that are received and used in producing APIs & Drug Products should be qualified using a system to ensure that raw materials are of acceptable identity, quality purity before use.
|
Price : $249.00
|
|
Instructor Jamie Jamshidi
|
Recorded Webinar
|
|
 |
|
|
|
|
|
|
Bringing FDA Pharmaceutical GMPs into the 21st Century
|
|
|
This Pharmaceutical training will review the key aspects of Pharmaceutical GMPs for the 21st Century and Quality Systems Approach to Pharmaceutical CGMP Regulations.
|
Price : $149.00
|
|
Instructor Tony Dunbar
|
Recorded Webinar
|
|
 |
|
|
|
|
|
|
Pharmaceutical Manufacturing Process Validation
|
|
|
This process validation training for Pharmaceutical Manufacturers will allow your process validation program to be executed quickly and efficiently and will ensure that the process validation you perform supports a successful pre-approval inspection.
|
Price : $249.00
|
|
Instructor Rodney E Thompson
|
Recorded Webinar
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Pharmaceutical Cleaning Validation
|
|
|
This webinar will cover the concepts of critical cleaning, FDA requirements and cleaning validation.
|
Price : $249.00
|
|
Instructor Jeff Phillips
|
Recorded Webinar
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Validation Requirements Based on ICH Q9
|
|
|
This program is specially designed for personnel in the Pharmaceutical and Biotechnology industries.
|
Price : $249.00
|
|
Instructor Jamie Jamshidi
|
Recorded Webinar
|
|
 |
|
|
|
|
|
|
Implementation of the ICH Q9 Guideline on Quality Risk Management
|
|
|
In this Quality Risk Management training develop and implement a policy for a Quality Risk Management Program and determine how to select the direct-impact systems and processes to apply your policy - formal QRM.
|
Price : $249.00
|
|
Instructor Miguel Montalvo
|
Recorded Webinar
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|